Publications

PEARL-III: 12 Weeks Of Abt-450/R/267+Abt-333 Achieved Svr In > 99% Of 419 Treatment-Naive Hcv Genotype 1B-Infected Adults With Or Without Ribavirin

AuthID
P-00P-A45

Author(s)

Ferenci, P

Nyberg, A

Enayati, P

Bernstein, D

Baruch, Y

Caruntu, FA

Chulanov, V

Janczewska, E

Younes, Z

Marinho, RT

Rizzardini, G

Gervain, J

Planas, R

Moreno, C

Xie, W

Cohen, D

King, M

Podsadecki, T

Reddy, KR

Document Type

Abstract

Year published

2014

Published

in JOURNAL OF HEPATOLOGY, ISSN: 0168-8278

Volume: 60, Issue: 1, Pages: S527-S527 (1)

Conference

49Th Annual International Liver Congress of the European-Association-For-The-Study-Of-The-Liver, Date: APR 09-13, 2014, Location: London, ENGLAND, Sponsors: European Assoc Study Liver

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/s0168-8278(14)61466-5

Wos: WOS:000362828600722

Source Identifiers

ISSN: 0168-8278

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

PEARL-III: 12 Weeks Of Abt-450/R/267+Abt-333 Achieved Svr In > 99% Of 419 Treatment-Naive Hcv Genotype 1B-Infected Adults With Or Without Ribavirin

Useful Links

Get Help

Federated Authentication (Click on the image)

PEARL-III: 12 Weeks Of Abt-450/R/267+Abt-333 Achieved Svr In > 99% Of 419 Treatment-Naive Hcv Genotype 1B-Infected Adults With Or Without Ribavirin

Useful Links

Get Help